Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo Trials
Pigment Cell & Melanoma Research · 2026-07 · 39 (4)
DOI: 10.1111/pcmr.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 01.07.2026. Verfasst von Hitaishi Mehta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Hitaishi Mehta, Muthu Sendhil Kumaran, Davinder Parsad, Keshavamurthy Vinay
Zitieren
APA
Mehta, H., Kumaran, M. S., Parsad, D., & Vinay, K. (2026). Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo Trials. Pigment Cell & Melanoma Research, 39(4). https://doi.org/10.1111/pcmr.70109
Vancouver
Mehta H, Kumaran MS, Parsad D, Vinay K. Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo Trials. Pigment Cell & Melanoma Research. 2026;39(4). doi:10.1111/pcmr.70109
BibTeX
@article{Mehta2026,
author = {Mehta, Hitaishi and Kumaran, Muthu Sendhil and Parsad, Davinder and Vinay, Keshavamurthy},
title = {Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo Trials},
journal = {Pigment Cell & Melanoma Research},
year = {2026},
volume = {39},
number = {4},
doi = {10.1111/pcmr.70109}
}
EUVIMED